A prospective, multicenter, randomized control trial of a real-time quality-control system for the colonoscopy examination of outpatient

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200063455

Enrollment

Unknown

Registered

2022-09-07

Start date

2022-09-12

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal adenoma

Interventions

AI-first group:AI-assisted colonoscopy is performed first, followed by standard colonoscopy

SC-first group:standard colonoscopy is performed first, followed by AI-assisted colonoscopy

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 year, any gender; 2. Requiring outpatient colonoscopy; 3. Able to sign or provide informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. History of inflammatory bowel disease, colorectal cancer or colorectal surgery; 2. Known or suspected intestinal obstruction, perforation or overt lower gastrointestinal bleeding; 3. History or high suspicion of familial adenomatous polyposis or serrated polyposis syndrome; 4. Contraindication for biopsy.

Design outcomes

Primary

Measure	Time frame
adenoma miss rate;	—

Secondary

Measure	Time frame
polyp miss rate;adenoma detection rate;polyp detection rate;adenoma per colonoscopy;polyp per colonoscopy;Boston bowel preparation scale;insertion time;withdrawal time;time for colonoscopic biopsy or resection;	—

Countries

China

Contacts

Public ContactQuan-Lin Li

Zhongshan Hospital, Fudan University

li.quanlin@zs-hospital.sh.cn+86 13564671882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026